Q2 2019 13F Holders as of 30 Jun 2019
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
160,955,072
-
Share change
-
-178,213
-
Total reported value
-
$11,136,717,667
-
Put/Call ratio
-
83%
-
Price per share
-
$69.21
-
Number of holders
-
317
-
Value change
-
-$19,298,142
-
Number of buys
-
137
-
Number of sells
-
160
Institutional Holders of SEATTLE GENETICS INC - COM (SGEN) as of Q2 2019
As of 30 Jun 2019,
SEATTLE GENETICS INC - COM (SGEN) was held by
317 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
160,955,072 shares.
The largest 10 holders included
BAKER BROS. ADVISORS LP, WELLINGTON MANAGEMENT GROUP LLP, Capital International Investors, PRIMECAP MANAGEMENT CO/CA/, VANGUARD GROUP INC, PRICE T ROWE ASSOCIATES INC /MD/, BlackRock Inc., BAILLIE GIFFORD & CO, STATE STREET CORP, and Matrix Capital Management Company, LP.
This page lists
317
institutional shareholders reporting positions in this security
for the Q2 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.